Stock Market

Ecolab Stock Down in Pre-Market Post Q2 Earnings Miss, Margins Expand


Ecolab Inc. ECL reported second-quarter 2025 adjusted earnings per share (EPS) of $1.89, up 12.5% year over year. However, the bottom line missed the Zacks Consensus Estimate by a penny.

GAAP EPS for the quarter was $1.84, up 7.6% year over year.

Revenues grossed $4.03 billion in the reported quarter, up 0.9% year over year. The metric topped the Zacks Consensus Estimate by 0.4%.

Ecolab’s organic sales were $3.88 billion, up 2.8% from the prior-year period’s level.

The year-over-year uptick in the second quarter of 2025 organic sales was driven by continued strong growth in the Institutional & Specialty, Pest Elimination and Life Sciences segments.

Shares of this company lost nearly 2.9% in today’s pre-market trading.

The Global Water segment’s fixed currency sales of $1.91 billion reflect 2.4% reported growth year over year. Organic sales were $1.89 billion, up 1.7% year over year, reflecting accelerating Food & Beverage sales growth and continued solid growth in Light & Heavy, which was partially offset by lower Paper sales.

The Global Institutional & Specialty arm’s fixed currency sales of $1.51 billion reflect a decline of 2.4% on a reported basis year over year. This resulted from the sale of the global surgical solutions business last year. Organic sales were $1.51 billion, up 3.5% year over year.

The Global Pest Elimination segment’s fixed currency sales of $311.3 million improved 7.3% year over year on a reported basis. Organic sales were $308.1 million, up 6.2% year over year. Improved organic sales growth was led by good gains in food & beverage, restaurants, healthcare and food retail, which continue to benefit from the One Ecolab growth strategy.

The Global Life Sciences arm’s fixed currency sales and organic sales were $176.7 million each, reflecting growth of 4.1% year over year, both on a reported and organic basis. Per management, year-over-year fixed currency sales and organic sales reflected double-digit growth in bioprocessing and pharmaceutical & personal care, which offset softer industrial water purification sales that were constrained by production limitations.

Ecolab Inc. Price, Consensus and EPS Surprise
Ecolab Inc. Price, Consensus and EPS Surprise

Ecolab Inc. price-consensus-eps-surprise-chart | Ecolab Inc. Quote

In the quarter under review, Ecolab’s gross profit improved 3.3% year over year to $1.80 billion. The gross margin expanded 100 basis points (bps) to 44.8%.

Selling, general and administrative expenses declined 0.7% to $1.07 billion year over year.



Source link

Leave a Response